Resolve Genetic Testing Prior Authorization and Documentation Before Testing Begins

CMS says the record supporting a diagnostic laboratory service should identify the specific ordered test, preserve diagnostic or other medical information supplied to the laboratory, and contain enough information to show the service is reasonable and necessary. Medicare coverage can involve an NCD or, when no national policy controls, an LCD. A current MolDX billing article illustrates test-specific billing and DEX Z-Code requirements in its listed contractor jurisdictions; it is not a nationwide molecular-testing rule.

• Confirm Original Medicare fee-for-service, service date, performing and billing laboratory, MAC jurisdiction, and who submitted the claim before selecting coverage material.
• Search the current Medicare Coverage Database for the exact test and review the applicable NCD, LCD, related article, revision status, effective dates, and listed jurisdiction together.
• Preserve the clinician's specific order or authenticated intent and the diagnosis or narrative information the clinician actually supplied; never infer a covered indication or clinical rationale.
• Where an applicable MolDX path controls, verify the test-specific identifier, current coverage status, billing context, and linked policy with qualified staff rather than applying one contractor article to every laboratory.
• Do not assume genetic testing universally requires Original Medicare prior authorization; record the current applicable requirement or an explicit no-match result.
• Use Form CMS-R-131 only for the applicable Original Medicare fee-for-service expected-denial situation and after qualified review; an ABN is not genetic-testing consent, a universal financial waiver, or a Medicare Advantage notice.

Human handoff: Revenue integrity or compliance confirms the Medicare coverage, order, jurisdiction, billing, and ABN path; the clinician supports medical facts; and patient-access staff deliver the approved explanation. Unresolved test identity, documentation, or potential liability remains on hold.

Sources for this path: Centers for Medicare & Medicaid Services, Centers for Medicare & Medicaid Services, Centers for Medicare & Medicaid Services, Centers for Medicare & Medicaid Services Medicare Coverage Database, Centers for Medicare & Medicaid Services

CMS defines an organization determination as a Medicare health plan decision about authorization or payment, an enrollee payment amount, or a service limit. The workflow therefore uses the identified plan's current coverage, network, authorization, organization-determination, notice, and appeal process instead of carrying an Original Medicare ABN or a contractor-specific MolDX instruction into Medicare Advantage by default.

• Verify the exact plan, product, network, performing laboratory, test, panel version, service date, and any delegated laboratory-benefit manager.
• Map only documented order, pathology, biomarker, pedigree, family-history, prior-testing, counseling, and consent facts requested by the current plan source.
• Separate authorization, organization determination, denial, payment information, member-cost information, and appeal states.
• Use current plan and CMS managed-care notice instructions rather than CMS-R-131 unless qualified review establishes a different applicable path.
• Route urgency and expedited-request questions to the clinician and authorization owner; the agent does not declare urgency or speak for the enrollee.

Human handoff: Authorization staff file through the approved plan channel and verify the response. Clinicians own clinical assertions, while patient access and compliance review plan notices and possible member liability. The agent cannot turn a portal status into guaranteed coverage or payment.

Sources for this path: Centers for Medicare & Medicaid Services, Centers for Medicare & Medicaid Services

The applicable Medicaid path depends on the state program, fee-for-service or managed-care arrangement, plan, provider status, service, and current instructions. Medicaid.gov also explains that legally liable third parties generally meet their obligation before Medicaid and that state-to-MCO contract terms can determine who administers third-party liability.

• Identify the state, fee-for-service or managed-care path, exact plan, provider and laboratory enrollment, test, service date, and current state or plan source.
• Verify test-specific authorization, documentation, counseling, consent, billing, and provider requirements without importing rules from another state or product.
• Resolve Medicare, commercial, workers' compensation, automobile, or other third-party coverage before assuming Medicaid is the first payment path.
• Do not assume a laboratory form or authorization denial creates patient liability; qualified staff must review the controlling state, plan, contract, and legal requirements.
• Keep dual-eligibility, managed-care delegation, and third-party-liability questions visible as separate work rather than selecting the most convenient payer.

Human handoff: A Medicaid authorization, billing, or compliance specialist verifies current state and managed-care requirements, enrollment, coordination order, and any patient communication. Dual-eligibility and contested third-party-liability cases go to qualified program and legal owners.

Sources for this path: Medicaid.gov

Commercial genetic and molecular testing requirements can differ by payer, employer or individual product, network, performing laboratory, delegated reviewer, test, indication, state, and effective date. An official UnitedHealthcare provider page is one concrete example of a plan-specific genetic and molecular testing program; it is evidence to research the exact program, not authority for other payers or products.

• Verify eligibility, benefits, network, performing laboratory, prior authorization, medical policy, delegated reviewer, contract, and service-date context for the exact member plan and test.
• Use the current payer source and required channel; a form found through search or saved from a prior request is not accepted without plan and date validation.
• Record approval, denial, modification, request for information, inability to verify, and expiration separately, including limitations stated by the payer.
• Treat test substitution, panel expansion, laboratory change, and germline-or-somatic change as possible reauthorization and patient-communication triggers.
• Send out-of-network, balance-billing, state-law, estimate, and consent questions to patient access, contract, compliance, or legal staff before testing or billing.

Human handoff: Authorization and contract staff interpret the actual plan and submit supported information; clinicians answer medical questions; patient-access staff present approved estimates or communications. Coverage and payment remain payer decisions, not agent outputs.

Sources for this path: UnitedHealthcare Provider Portal

CMS explains that no-fault, liability, or workers' compensation coverage may pay before Medicare for related services, while Medicaid guidance also lists workers' compensation and liability resources among potential third parties. That coordination principle does not determine whether a particular genetic or molecular test is related to an injury or which jurisdiction's authorization rules control.

• Use only documented human-supplied information to identify a possible work injury, automobile event, liability claim, employer plan, settlement, or other responsible source.
• Verify jurisdiction, claim administrator, accepted body part or condition, test relationship, authorization channel, network, and billing instructions with qualified staff.
• Keep clinical relevance, legal causation, claim acceptance, coverage, and payment as separate decisions; the agent cannot infer any of them.
• Coordinate Medicare, Medicaid, commercial, and liability responses in the required order without exposing claim or patient values in marketing analytics.
• Route disputes, conditional-payment questions, settlements, denials, and patient-billing questions to workers' compensation, recovery, compliance, or legal specialists.

Human handoff: A workers' compensation or liability coordinator establishes the responsible payer and authorization path; a clinician addresses clinical relevance; and compliance or legal staff resolve contested causation, coordination, settlement, and patient-liability issues.

Sources for this path: Centers for Medicare & Medicaid Services, Medicaid.gov

CMS says people in the United States who do not have insurance or are not using it generally have good-faith-estimate rights in specified scheduled-care circumstances. This is a separate patient-access path; it does not establish clinical appropriateness, replace genetic-testing consent, or serve as an insured commercial authorization workflow.

• Confirm with patient-access staff that the person is uninsured or choosing not to use insurance and that the current good-faith-estimate conditions apply.
• Use the approved test and expected-charge inputs from accountable systems without presenting the estimate as a final bill or a coverage decision.
• Revisit the estimate if the panel, method, laboratory, specimen plan, or expected service changes under the organization's current procedure.
• Keep financial communication separate from informed consent, genetic counseling, clinical test selection, and laboratory material release.

Human handoff: Patient-access and compliance staff confirm applicability, prepare and explain the approved estimate, and handle disputes or changed charges. Clinicians and laboratory staff retain their separate authority over testing and consent.

Sources for this path: Centers for Medicare & Medicaid Services